[EN] TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS<br/>[FR] COMPOSÉS DE TÉTRAHYDROISOQUINOLÉINE UTILISÉS EN TANT QU'ACTIVATEURS DE NRF2
申请人:C4X DISCOVERY LTD
公开号:WO2021214472A1
公开(公告)日:2021-10-28
The present invention relates to compounds that are Nrf2 activators. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with Nrf2 activation.
本发明涉及一种Nrf2激活剂化合物。这些化合物具有本文中定义的结构式I。本发明还涉及制备这些化合物的方法,包括含有它们的药物组合物,以及它们在与Nrf2激活相关的疾病或紊乱治疗中的用途。